Literature DB >> 33822280

Associations of preoperative stroke and tranexamic acid administration with convulsive seizures in valvular open-heart surgery.

Nikolai Hulde1, Armin Zittermann2, Marcus-André Deutsch3, Vera von Dossow1, Jan F Gummert3, Andreas Koster1.   

Abstract

In cardiac surgery, use of the antifibrinolytic agent tranexamic acid (TXA) and acute perioperative stroke are both associated with convulsive seizures. We hypothesized that an older (preoperative) stroke increases the risk of TXA-associated seizures as well. To test this hypothesis, we retrospectively analyzed data from 16,110 patients who had undergone open-heart valvular surgery at our institution between 2009 and 2020. The dosing of TXA was moderate. Use of TXA and a history of stroke were both independently associated with convulsive seizure with an adjusted odds ratio (OR) of 2.40 (95%CI: 1.71-3.37) and 1.79 (95%CI: 1.27-2.54), respectively. Compared to patients without TXA administration, the adjusted OR of experiencing a seizure in TXA patients without a history of stroke was 2.44 (95%CI: 1.71-3.46) and in patients receiving TXA with a history of stroke 4.30 (95%CI: 2.65-6.99). However, there was no significant interaction between TXA use and preoperative stroke on convulsive seizures (P = 0.77). Compared to patients without seizure, for patients with seizure, the inverse probability-weighted ORs of in-hospital mortality and 30-day mortality were 3.58 (95%CI: 2.20-5.83) and 4.04 (95%CI: 2.34-6.98), respectively. We conclude that, in patients undergoing open-heart surgery, a history of stroke is independently associated with convulsive seizures but is not a contraindication for TXA use.

Entities:  

Keywords:  30-day mortality; In-hospital mortality; Seizure; Stroke; Tranexamic acid

Year:  2021        PMID: 33822280     DOI: 10.1007/s00540-021-02924-w

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  1 in total

1.  Reply to Sarridou et al.

Authors:  Andreas Koster; Nikolai Hulde; Armin Zittermann
Journal:  J Anesth       Date:  2021-07-16       Impact factor: 2.078

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.